Falls River Group, LLC
Falls River Group describes itself as an independent M&A advisor headquartered in Naples, Florida, with offices in Boston, Paris, and Detroit. Its sector focus includes Life Sciences & Healthcare, Consumer & Retail, and Industrials.
What stands out about Falls River Group, LLC
Falls River Group provides sell-side, buy-side, capital, and strategic advisory services for middle-market transactions. Its stated process is targeted, confidential, and bespoke, and its public transaction examples include businesses in life sciences, healthcare, consumer, retail, and industrial markets.[1][2][5][6]
What does Falls River Group, LLC do?
Falls River Group describes itself as an independent M&A advisor headquartered in Naples, Florida, with offices in Boston, Paris, and Detroit. The firm states that it has focused on independent M&A advice and deal execution for middle-market clients since 1992.
Falls River Group states that its track record includes more than 300 middle-market M&A transactions with enterprise value up to $500 million.[1]
Falls River Group publicly offers sell-side M&A advisory, buy-side M&A advisory, capital advisory, and strategic advisory services.
Its stated sell-side work can include minority partnerships, majority recapitalizations with financial sponsors, and full sales to strategic acquirers.[2]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring Falls River Group, LLC?
For an owner evaluating a sale or recapitalization advisor, Falls River Group’s public materials establish a middle-market focus, sector coverage across Life Sciences & Healthcare, Consumer & Retail, and Industrials, and a stated confidential process involving buyer-universe development, positioning, diligence, and negotiations.
An owner should confirm which current team members would lead the engagement, which disclosed transactions are comparable, the applicable fee and exclusivity terms, the intended buyer universe, and how securities-related activities would be handled through StillPoint Capital, LLC.[1][2][3][5]
Which disclosed transactions are relevant to the owner's business, and which current team members would lead the engagement
What are the firm's current revenue, EBITDA, enterprise-value, and ownership criteria for accepting an engagement
What are the proposed retainer, success fee, minimum fee, expense reimbursement, tail, termination, and exclusivity terms
What size transactions and clients does Falls River Group, LLC focus on?
Falls River Group identifies Life Sciences & Healthcare, Consumer & Retail, and Industrials as its principal sector areas.
Publicly listed subsectors include bioprocessing solutions, single-use systems, life-science research tools, medical devices, analytical services, biotechnology, diagnostics, cold-chain storage and logistics, pharmaceuticals, specialized manufacturing, HVAC equipment and services, pumps, valves and flow control, materials and chemicals, packaging, filtration, value-added distribution, and building products and services.[3][4]
The official Falls River Group transactions page identifies Helmer Scientific, Valley Vet, Farrar Scientific, Nature’s Logic, Azimuth Technology, Drs. Foster & Smith, and JanTran as client transaction examples.
IMAP reports that Falls River Group acted as the exclusive M&A advisor to Helmer Scientific on its sale to Trane Technologies. IMAP also reports that Falls River Group and Zelman Partners served as financial advisors to Sumitomo on the acquisition of Crescent Communities.[5][6][7]
The firm states that its sell-side advisory work can cover minority partnerships, majority recapitalizations with financial sponsors, and full sales to strategic acquirers. Its publicly offered services also include buy-side M&A, capital advisory, and strategic advisory.[2]
What does Falls River Group, LLC publicly disclose about fees, process and engagement terms?
The cited official capabilities page does not publish a universal fee schedule, success-fee percentage, minimum fee, tail period, or termination schedule.
The cited official about page states an enterprise-value ceiling of up to $500 million but does not publish a universal revenue, EBITDA, minimum enterprise-value, or other quantitative engagement threshold. The cited IMAP Helmer Scientific transaction page states that the specific terms of that transaction were not disclosed.[1][2][6]
Falls River Group’s official transactions page states that securities transactions are conducted through StillPoint Capital, LLC, Tampa, Florida. FINRA’s firm-level BrokerCheck report identifies StillPoint Capital, LLC as regulated by FINRA and registered with the SEC and one self-regulatory organization.[5][8]
Falls River Group describes its process as targeted, confidential, and bespoke. The stated approach includes identifying and marketing a client’s differentiated value proposition, cultivating a buyer universe, and managing diligence and negotiations.[2]
Questions to ask before hiring Falls River Group, LLC
Which disclosed transactions are relevant to the owner's business, and which current team members would lead the engagement?
What are the firm's current revenue, EBITDA, enterprise-value, and ownership criteria for accepting an engagement?
What are the proposed retainer, success fee, minimum fee, expense reimbursement, tail, termination, and exclusivity terms?
Which strategic, private-equity, and family-office buyers would be targeted?
How are securities-related activities handled through StillPoint Capital, LLC, and which activities are performed directly by Falls River Group?
What transaction timetable and owner-management involvement would Falls River Group recommend for the proposed engagement?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Industry / market focus
- Industry / market focus
- Transaction size / criteria
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- FINRA regulatory record
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.